Intrauterine Embryo Development With ANECOVA Device

Multi-Center Evaluation Program NCVD1H Intrauterine Embryo'S Development Assisted by ANECOVA ACVd1 Device

Status

Terminated

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00480103

Acronym

ANECOVA

Enrollment

Unknown

Registered

2007-05-30

Start date

2007-08-31

Completion date

2008-11-30

Last updated

2011-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Embryo morphological and chromosomal features, Implantation and pregnancy rate

Brief summary

We aim to compare the morphological and chromosomal features of human embryos cultured In Vitro versus those developed in a new In Vivo culture system with encapsulation in utero as well as implantation and pregnancy rate.

Interventions

DEVICEin vivo (ANECOVA D-1) or in vitro culture in 25-µl droplets of cleavage medium (Medicult®) under paraffin oil

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SCREENING

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 36 Years

Healthy volunteers

Yes

Inclusion criteria

* Women age below 37 * Hormonal serum levels within normal ranges (FSH, LH, E2, PRL, P4, T4, TSH) * Negative serologic screening for HIV, Hep B and C * No uterine or ovarian alterations found by ultrasound * Normal BMI (19 - 29 kg/m2).

Exclusion criteria

* At least 8 stage MII oocytes are not retrieved * Endometriosis or PCO * Severe male factor in the partner

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026